A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation.

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2015

At a glance

  • Drugs Axelopran (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Sponsors Theravance
  • Most Recent Events

    • 21 May 2013 Results presented at the Digestive Disease Week 2013.
    • 11 May 2013 Results from a prespecified week-to-week analysis presented at the 32nd Annual Scientific Meeting of the American Pain Society.
    • 11 May 2013 Effects of treatment on pain and opioid dose outcomes presented at the 32nd Annual Scientific Meeting of the American Pain Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top